Advisor Group’s Fate Therapeutics FATE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $16K | Hold |
800
| – | – | ﹤0.01% | 4065 |
|
|
2019
Q3 | $12K | Hold |
800
| – | – | ﹤0.01% | 4228 |
|
|
2019
Q2 | $16K | Sell |
800
-300
| -27% | -$6K | ﹤0.01% | 4091 |
|
|
2019
Q1 | $19K | Hold |
1,100
| – | – | ﹤0.01% | 3998 |
|
|
2018
Q4 | $14K | Sell |
1,100
-415
| -27% | -$5.28K | ﹤0.01% | 4009 |
|
|
2018
Q3 | $24K | Sell |
1,515
-85
| -5% | -$1.35K | ﹤0.01% | 3767 |
|
|
2018
Q2 | $18K | Hold |
1,600
| – | – | ﹤0.01% | 3763 |
|
|
2018
Q1 | $16K | Sell |
1,600
-700
| -30% | -$7K | ﹤0.01% | 3811 |
|
|
2017
Q4 | $14K | Hold |
2,300
| – | – | ﹤0.01% | 3884 |
|
|
2017
Q3 | $9K | Sell |
2,300
-300
| -12% | -$1.17K | ﹤0.01% | 4033 |
|
|
2017
Q2 | $8K | Buy |
2,600
+600
| +30% | +$1.85K | ﹤0.01% | 4029 |
|
|
2017
Q1 | $9K | Hold |
2,000
| – | – | ﹤0.01% | 3833 |
|
|
2016
Q4 | $5K | Hold |
2,000
| – | – | ﹤0.01% | 3916 |
|
|
2016
Q3 | $6K | Buy |
+2,000
| New | +$6K | ﹤0.01% | 3806 |
|